Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

PowerSecure International Inc. (POWR): Becker Drapkin Management Is Pretty Active

Matthew Drapkin and Steven R. Becker’s Becker Drapkin Management has been quite active in relation to PowerSecure International, Inc. (NASDAQ:POWR) over the third quarter of 2014. Over the past two months, the fund filed five 13D amendments disclosing changes in its position. In the last one of them, the fund declared beneficial ownership of 1.39 million shares of Common Stock (which includes 280,000 shares of Common Stock underlying over-the-counter American-style call options exercisable until December 20, 2014), down from 1.41 million declared in mid-August, but up from the 1.35 million disclosed by the end of the second quarter of 2014.

This position represents approximately 6.25% of PowerSecure International, Inc. (NASDAQ:POWR)’s outstanding shares of Common Stock, and makes of Becker Drapkin Management the largest hedge fund shareholder –amongst those we keep track of- in the company. Other major hedge funds betting on this company are Philip Hempleman’s Ardsley Partners, which started a position in the company over the second quarter of 2014, with 320,000 shares, worth more than $13 million, and John Bader’s Halcyon Asset Management, which almost doubled its stake over the quarter, to 241,250 shares.

PowerSecure International, Inc. (POWR)

PowerSecure International, Inc. (NASDAQ:POWR) is a $221.76 million market cap company that provides products and services to electric utilities, and their commercial, institutional and industrial customers. Although its margins and returns are still negative, analysts recommend the stock, and expect it to return about 50% over the next 12 months. In addition, Northland Capital recently initiated coverage with an “outperform” rating, while Zacks rated it as a “Strong Buy,” mainly in account of its solid earnings estimate revision activity.

Becker Drapkin Management is a Dallas, Texas-based hedge fund managed by Matthew Drapkin and Steven R. Becker’s Becker. It was founded in 2004, and focuses on small-cap value situations in the U.S. equity markets. It last disclosed an equity portfolio –for the second quarter of the year- worth more than $162 million, mainly focused on information technology, and utilities and telecommunications stocks, which account for 34.3% and 24.1% of its total equity portfolio, respectively. Its largest bets are placed on Comverse Inc (NASDAQ:CNSI) and XO Group Inc (NYSE:XOXO). The fund owns $38 million (1.44 million shares) and $23 million (1.94 million shares) of these companies, respectively. D. E. Shaw also holds stakes in both these companies. The fund owns 184,246 shares of Comverse Inc (NASDAQ:CNSI), and 296,740 shares of XO Group Inc (NYSE:XOXO)

Disclosure: Javier Hasse holds no positions in any stocks or funds mentioned

Warren Buffett and BillionairesFree Report: Warren Buffett and 12 Billionaires Are Crazy About These 7 Stocks

Let Warren Buffett, David Einhorn, George Soros, and David Tepper WORK FOR YOU. If you want to beat the low cost index funds by an average of 6 percentage points per year look no further than Warren Buffett’s stock picks. That’s the margin Buffett’s stock picks outperformed the market since 2008. In this free report, Insider Monkey’s market beating research team identified 7 stocks Warren Buffett and 12 other billionaires are crazy about. CLICK HERE NOW for all the details.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!